Latest Data & Signals Issued

Signal Type Signal Value Data
Score -0.773 1 day ( 0 % )
Last Price $12.66 7.11 %
High/ Low $11.73 - $12.88 9.80%
Chg 7 Days 6.39 % $11.90 $12.66
Chg 30 Days -14.52 % $14.81 $12.66
Chg 12 mos -45.67 % $23.30 $12.66
Trend - 3 mos -25.56 % Width: 18.61 %
Trend - 12 mos -29.25 % Width: 81.74 %
Pred. range - 3 mos $8.62 - $10.22 -31.92 % - -19.25 %
Pred. range - 12 mos $6.75 - $12.26 -46.70 % - -3.13 %
Short MA avg 3 mos Buy Apr 30, 2024 - 2 days
Long MA avg 3 mos Buy Feb 26, 2024 - 47 days
Short/Long MA avg 3 mos Sell Feb 05, 2024 - 61 days
Short MA avg 12 mos Buy Apr 08, 2024 - 18 days
Long MA avg 12 mos Sell Mar 05, 2024 - 41 days
Short/Long MA avg 12 mos Sell Mar 14, 2024 - 34 days
Pivot Short Buy Apr 26, 2024 - 4 days
Bollinger Buy Apr 18, 2024 - 10 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!

About Pliant Therapeutics Inc.

Pliant Therapeutics. Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a trials. The company also develops PLN-1474, a small-molecule selective inhibitor of avß1, which complet... PLRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT